LBA51 EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)M. Gogishvili,T. Melkadze,T. Makharadze,D. Giorgadze,M. Dvorkin,K.D. Penkov,K. Laktionov,G. Nemsadze,M. Nechaeva,I. Rozhkova,E. Kalinka,C. Gessner, B. Moreno-Jaime, R. Passalacqua, S. Li,K. McGuire,R.G.W. Quek,G. Gullo,P. RietschelAnnals of Oncology（2021）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
